Alzheimer’s Therapeutics Targeting Amyloid Beta 1 – 42 Oligomers I: Abeta42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive DeficitsBy QPS / June 5, 2023